Allergan plc (NYSE:AGN)
| 188.34 Delayed Data As of Dec 13 |  +0.07 / +0.04%Today’s Change | 114.27 Today|||52-Week Range 190.41 | +40.91% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 3.9B | 4.1B | 3.6B | 4.1B | |
| Cost of Goods Sold | 534.4M | 534.2M | 428.1M | 577.3M | ||
| Depreciation And Amortization | 1.6B | 1.6B | 1.4B | 1.5B | ||
| Operating Expenses | Gross Income | 1.7B | 1.9B | 1.7B | 2.1B | |
| General Expenses | 1.5B | 1.8B | 1.5B | 1.6B | ||
| Research And Development | 445.6M | 674.5M | 432.0M | 447.7M | ||
| Total Operating Expenses | 3.6B | 4.0B | 3.4B | 3.6B | ||
| Non-Operating Expenses | Operating Income | 268.7M | 116.5M | 224.1M | 474.5M | |
| Extraordinary Credit | 21.4M | 14.8M | 10.4M | 100.0K | ||
| Extraordinary Charge | -41.3M | -2.9B | -2.5B | -1.6B | ||
| Interest Expense On Debt | 220.4M | 210.2M | 201.8M | 195.4M | ||
| Other Expenses | 138.7M | -2.6B | 2.1M | -137.5M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 177.1M | -5.6B | -2.5B | -1.5B | |
| Income Taxes | -213.4M | -1.3B | -68.6M | -301.6M | ||
| Minority Interest | -1.6M | -4.0M | -700.0K | -4.1M | ||
| Net Income | -37.9M | -4.3B | -2.4B | -1.8B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 339.0M | 335.1M | 332.0M | 327.8M | |
| Shares To Calculate EPS Diluted | 339.0M | 335.1M | 332.0M | 327.8M | ||
| Earnings Per Share | EPS | -$0.11 | -$12.83 | -$7.25 | -$5.37 | |
| EPS Diluted | -$0.11 | -$12.83 | -$7.25 | -$5.37 | ||
